FLT1 and renal cell carcinoma: However, the present findings unexpectedly revealed that the FLT uptake level in the RCC xenograft significantly increased following the sorafenib treatment without significant changes in the tumor proliferation marker level (Ki-67 labeling index) or the tumor volume.